Index Catalog // ScholarsArchive@OSU

Creator:: Moran, Andrew E., Odden, Michelle C., Thanataveerat, Anusorn, and et al.
Abstract:: BACKGROUND: On the basis of the 2014 guidelines for hypertension therapy in the United States, many eligible adults remain untreated. We projected the cost-effectiveness of treating hypertension in U.S. adults according to the 2014 guidelines. METHODS: We used the Cardiovascular Disease Policy Model to simulate drug-treatment and monitoring costs, costs...

Creator:: Moran, Andrew E., Odden, Michelle C., Thanataveerat, Anusorn, and et al.
Abstract:: BACKGROUND: On the basis of the 2014 guidelines for hypertension therapy in the United States, many eligible adults remain untreated. We projected the cost-effectiveness of treating hypertension in U.S. adults according to the 2014 guidelines. METHODS: We used the Cardiovascular Disease Policy Model to simulate drug-treatment and monitoring costs, costs...

Creator:: Moran, Andrew E., Odden, Michelle C., Thanataveerat, Anusorn, and et al.
Abstract:: BACKGROUND: On the basis of the 2014 guidelines for hypertension therapy in the United States, many eligible adults remain untreated. We projected the cost-effectiveness of treating hypertension in U.S. adults according to the 2014 guidelines. METHODS: We used the Cardiovascular Disease Policy Model to simulate drug-treatment and monitoring costs, costs...

Creator:: Moran, Andrew E., Odden, Michelle C., Thanataveerat, Anusorn, Tzong, Keane Y., Rasmussen, Petra W., Guzman, David, Williams, Lawrence, Bibbins-Domingo, Kirsten, Coxson, Pamela G., and Goldman, Lee
Abstract:: BACKGROUND: On the basis of the 2014 guidelines for hypertension therapy in the United States, many eligible adults remain untreated. We projected the cost-effectiveness of treating hypertension in U.S. adults according to the 2014 guidelines. METHODS: We used the Cardiovascular Disease Policy Model to simulate drug-treatment and monitoring costs, costs...
Resource Type:: Article

ScholarsArchive@OSU